Knoll Capital Management, LLC Ampio Pharmaceuticals, Inc. Transaction History

Knoll Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 14, 2018	SELL	$0.44 - $3.02 $1.14 Million - $7.84 Million	-2,595,484 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$0.38 - $0.66 $986,283 - $1.71 Million	2,595,484	2,595,484 $1.61 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.